Sleep Apnea Treatment Devices Market Size, Trends, Global Growth, Insights and Forecast Research Report 2026

The global sleep apnea treatment devices market size is set to touch USD 8.97 billion by 2026, exhibiting a CAGR of 8.2% during the forecast period. Steadily climbing demand for sleep apnea devices, stemming from a consistent spread in the prevalence of sleep apnea, will be a major growth driver for this market, shares Fortune Business Insights™ in its new report, titled “Sleep Apnea Treatment Devices Market Size, Share & Industry Analysis, By Device Type (Positive Airway Pressure (PAP) Devices, Oral Appliances, Masks & Accessories, and Others), By End User (Sleep Laboratories & Clinics, and Homecare & Other Settings), and Regional Forecast, 2019-2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com ... ket-102694

List of Players Covered in the Report:

Braebon Medical Corporation
Glidewell
Oventus
Fisher & Paykel Healthcare Limited
ResMed
DeVilbiss Healthcare
BMC Medical Co., Ltd.
SomnoMed
Koninklijke Philips N.V.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com ... ket-102694

A study published in the medical journal Lancet in 2019 found that nearly 1 billion people worldwide suffer from Obstructive Sleep Apnea (OSA). Regionally, too, the statistics conform to the global trends. For instance, the European Respiratory Society estimates that 13% to 32% of the geriatric population in Europe suffer from sleep apnea. As a result, the demand for sleep apnea treatment is escalating and driving the sleep apnea treatment devices market trends. Furthermore, the incidence of OSA is spiking owing to the rising prevalence of obesity, the most common cause for interrupted sleep, which according to the World Health Organization, presently affects close to 650 million adults worldwide.

Competitive Landscape

Innovative Product Offerings to Characterize Market Competition

Key players in this market are focusing on consolidating their position, according to the sleep apnea treatment devices market report. These companies aim to entrench themselves in this market through frequent launch of innovative products, which also helps them diversify their portfolio of offerings to consumers.

Industry Developments:

April 2019: San Diego-based medical devices manufacturer ResMed launched its novel top-of-head, sleep apnea solution called the AirFit P30i. The mask features a tube-up mechanism that enables the patient to sleep in any position without causing any discomfort.
September 2019: Koninklijke Philips N.V., commercially introduced its sleep position therapy product for Positional Obstructive Sleep Apnea (POSA) patients, the Philips NightBalance. This is the company’s clinically-verified alternative to mask-based treatments for OSA, which also provides doctors and patients with real-time data.

Well, right away I saw some reporting that's incorrect. Apnea is not thought (now) to be caused by obesity, but rather, obesity may be caused by apnea, and apnea itself caused by anatomy - small jaws that narrow the airway, large tongues falling back and blocking airways, etc. etc. And so many 'failures' of Cpap are as much due to bad information given to new users, the 'wrong' help extended by doctors who unfortunately don't know much about how equipment works or how to tweak it for maximum benefit, and not enough help passed on to the industry (which includes doctors) that accepts 'failure' as an option. When patients are given the right information and helped with adjustments to their Cpap set-up, it is a noninvasive and easily tolerated way to treat apnea.

Two identical threads, identical posts; testing the waters?
Preparatory to a spam attack?
Lock up your children; hide your women!

chunkyfrog wrote: ↑

Wed Sep 23, 2020 11:24 am

Two identical threads, identical posts; testing the waters?
Preparatory to a spam attack?
Lock up your children; hide your women!

Never attribute to malice that which can be adequately explained by stupidity.

chunkyfrog wrote: ↑

Wed Sep 23, 2020 11:24 am

Two identical threads, identical posts; testing the waters?

Now one thread....I removed the other thread as a duplicate post.

I didn't approve either. Carolyn did. I know it has been reported as spam. Carolyn will have to make that decision.

Pugsy wrote: ↑

Wed Sep 23, 2020 11:57 am

chunkyfrog wrote: ↑

Wed Sep 23, 2020 11:24 am

Two identical threads, identical posts; testing the waters?

Now one thread....I removed the other thread as a duplicate post.

I didn't approve either. Carolyn did. I know it has been reported as spam. Carolyn will have to make that decision.

0ld spam sliding all the way into the future spam (2026), maybe a good thing, for now not sure what 2026 would look like if it was enen going to be here. Jim